Silver Book Fact

There are currently 312 medicines in development for heart disease and stroke.

PhRMA. 2009 Report: Medicines in development for heart disease and stroke. Washington, D.C.: PhRMA; 2009. http://www.phrma.org/sites/default/files/653/heart_2009

Reference

Title
2009 Report: Medicines in development for heart disease and stroke
Publisher
PhRMA
Publication Date
2009
Authors
PhRMA
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Per-patient annual cost of treating stroke in atrial fibrillation patients
    The per-patient annual cost of treating stroke in atrial fibrillation patients was found to be $1,485 in a wellcontrolled anti-coagulation clinic, $3,710 for those receiving warfarin in routine medical care,…  
  • Effectiveness of an oral pharmacologic agent in preventing venous thrombosis
    An oral pharmacologic agent has been demonstrated to be at least as effective as an injectable anticoagulant in the prevention of venous thrombosis following hip replacement.  
  • In 1996, fewer than 2 in 3 patients were receiving beta-blocker drugs to prevent a second heart attack. In 2006, more than 97% of heart attack patients received these treatments,…  
  • New approaches are under development to reduce ischemic stroke damage and other damage occuring because of stroke.  
  • Identifying individuals at high risk for developing AFib
    Using simple bedside measures, identification of individuals at risk for developing atrial fibrillation is feasible. Selecting high-risk individuals for inclusion in atrial fibrillation prevention trials may also enhance prevention strategies.